Chronic kidney disease (CKD) is an emerging non-communicable disease worldwide. The Arab countries (including Jordan) have a high prevalence of CKD risk factors, e.g. diabetes, obesity and hypertension.
Triumpharma network of Nephrologists have participated in several Nephrology global trials. This has allowed us to build excellent knowledge on how to overcome the challenges of performing kidney diseases trials. We understand these challenges; so we can help you by providing the required consultation for the product development programs in applying several strategies to improve recruitment into kidney disease trials including: optimizing trial design, selecting a suitable trial population, calculating an appropriate sample size and proper selection of outcomes for assessing treatment effects.
Triumpharma experience in Nephrology Clinical trials
Triumpharma has conducted several Nephrology related clinical trials to evaluate the pharmacokinetics, safety and tolerability of either single dose drug when administered alone and after multiple doses, to assess the potential effect of the drug in the steady state pharmacokinetics, and to assess the multiple dose pharmacokinetics and pharmacodynamics.